Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jesnowski

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Gene Therapy|August 13, 2005
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamideS Samel, M Keese, A Lux, et al.
British Journal of Cancer|September 19, 2007
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancerH Kayed, X Jiang, S Keleg, et al.
Virchows Archiv : an International Journal of Pathology|July 27, 2001
Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-rasM Löhr, P Müller, I Zauner, et al.
Gene Therapy|May 18, 1999
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450M Löhr, P Müller, P Karle, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapyP Karle, P Müller, R Renz, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Injection of encapsulated cells producing an ifosfamide-activating cytochrome P450 for targeted chemotherapy to pancreatic tumorsP Müller, R Jesnowski, P Karle, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 3, 1999
Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II studyM Löhr, Z T Bago, H Bergmeister, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Gene Therapy|August 13, 2005
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamideS Samel, M Keese, A Lux, et al.
British Journal of Cancer|September 19, 2007
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancerH Kayed, X Jiang, S Keleg, et al.
Virchows Archiv : an International Journal of Pathology|July 27, 2001
Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-rasM Löhr, P Müller, I Zauner, et al.
Gene Therapy|May 18, 1999
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450M Löhr, P Müller, P Karle, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapyP Karle, P Müller, R Renz, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Injection of encapsulated cells producing an ifosfamide-activating cytochrome P450 for targeted chemotherapy to pancreatic tumorsP Müller, R Jesnowski, P Karle, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 3, 1999
Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II studyM Löhr, Z T Bago, H Bergmeister, et al.
Pageof 2